2nd Quarter - Report

INNOVATIVE FEDERAL STRATEGIES, LLC for ADURO BIOTECH

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 5293 / S. 3000 Department of Defense Appropriations Act, 2017, Titles IV and VI, all provisions relating to cancer and infectious disease vaccines.

LobbyistCovered position, as disclosed
DAVID FREDERICK KILIAN —
CARL KIME —
KALI MATALON —
LETITIA WHITE —

Contacted: Vice President of the U.S.; SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3000 (114th), H.R. 5293 (114th)

Government Issues GOV

Contacted White House Staff to Request a meeting on Moodshot Cancer Initiatives.

LobbyistCovered position, as disclosed
DAVID FREDERICK KILIAN —
CARL KIME New —
KALI MATALON —
LETITIA WHITE —

Contacted: SENATE; Vice President of the U.S.; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.